• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Cellbxhealth PLC (CLBX)

ORD 0.05P
Sell: 0.55p|Buy: 0.65p|Change: 0 (0%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Company profile

CelLBxHealth PLC is engaged in the development and commercialisation of the Parsortix platform, with deployment in liquid biopsy - non-invasive cancer diagnostics. It operates in single segment of commercialisation of its Parsortix cell separation platform. It generates revenue from contracts with customers in the research-use market, with customers located across multiple geographic regions. Geographically it operates in UK, Europe, North America, and Rest of World with majority of revenue deriving from Europe and North America.

Address

10 Nugent Road
The Surrey Research Park
Guildford
Surrey
GBR
GU2 7AF

Telephone

+44 1483295830

Website

https://www.cellbxhealth.com

Sector 

Healthcare

Forecast key dates

NameKey Date
CelLBxHealth PLC Second Quarter Earnings Results for 20272027-07-15T00:00:00
CelLBxHealth PLC Annual General Meeting for 20262027-07-14T08:00:00
CelLBxHealth PLC Fourth Quarter Earnings Conference Call for 20262027-06-22T10:00:00
CelLBxHealth PLC Fourth Quarter Earnings Results for 20262027-06-22T00:00:00
CelLBxHealth PLC Annual Report for 20262027-06-18T00:00:00

Previous key dates

NameKey Date
CelLBxHealth PLC Second Quarter Earnings Results for 20262026-07-15T00:00:00
CelLBxHealth PLC Annual General Meeting for 20252026-07-14T08:00:00
CelLBxHealth PLC Fourth Quarter Earnings Conference Call for 20252026-06-22T10:00:00
CelLBxHealth PLC Fourth Quarter Earnings Result for 20252026-06-22T00:00:00
CelLBxHealth PLC Annual Report for 20252026-06-19T00:00:00
CelLBxHealth PLC Investors Meet 20252025-11-26T14:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.